Big Pharma Buys Access to This Promising Biotech Pipeline DailyFinance The five drugs are each antibody-based drugs targeting antithetic proteins involved in inflammation, which affects everything from psoriasis to asthma to Crohn's disease. The farthest along, brodalumab, is battling it out with Eli Lilly's (NYS: LLY) ... and more » Link To Article
No comments:
Post a Comment